|
Gerald J. Vardzel, Jr., B.A. - CEO - has over 17 years of corporate experience in healthcare related businesses, including niche pharmaceutical applications, clinical and non-clinical pharmaceutical business segments, medical testing and device markets. Mr. Vardzel's operational expertise includes strategic planning, business intelligence, mergers and acquisitions and new market development in both start-up and established corporate settings. He has most recently served as acting Vice President of Business Development for Gene Express and has been instrumental in its strategic direction and initial growth. Previously, Mr. Vardzel was Vice President of the Pharmaceutical Development Center, where he doubled growth and positioned its acquisition by aaiPharma. He has held many key management positions at Becton Dickinson including Worldwide Marketing Manager. Mr. Vardzel has consulted for small to mid-size equity firms as an executive affiliate in the healthcare business to determine acquisition feasibility and growth. He currently is on the board of directors for JKM Group, a consulting, acquisitions, divestures and real estate holding company. Mr. Vardzel received his bachelor's degree from the University of Pittsburgh and has taken graduate courses towards an MBA. | 